Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
2003 1
2004 1
2005 2
2006 1
2007 1
2010 1
2011 2
2012 3
2013 1
2014 3
2015 7
2016 6
2017 7
2018 6
2019 5
2020 8
2021 11
2022 9
2023 5
2024 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

82 results

Results by year

Filters applied: . Clear all
Page 1
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer.
Modi S, Jacot W, Yamashita T, Sohn J, Vidal M, Tokunaga E, Tsurutani J, Ueno NT, Prat A, Chae YS, Lee KS, Niikura N, Park YH, Xu B, Wang X, Gil-Gil M, Li W, Pierga JY, Im SA, Moore HCF, Rugo HS, Yerushalmi R, Zagouri F, Gombos A, Kim SB, Liu Q, Luo T, Saura C, Schmid P, Sun T, Gambhire D, Yung L, Wang Y, Singh J, Vitazka P, Meinhardt G, Harbeck N, Cameron DA; DESTINY-Breast04 Trial Investigators. Modi S, et al. N Engl J Med. 2022 Jul 7;387(1):9-20. doi: 10.1056/NEJMoa2203690. Epub 2022 Jun 5. N Engl J Med. 2022. PMID: 35665782 Free PMC article. Clinical Trial.
The History of Early Breast Cancer Treatment.
Ben-Dror J, Shalamov M, Sonnenblick A. Ben-Dror J, et al. Among authors: sonnenblick a. Genes (Basel). 2022 May 27;13(6):960. doi: 10.3390/genes13060960. Genes (Basel). 2022. PMID: 35741721 Free PMC article. Review.
Pregnancy After Breast Cancer in Young BRCA Carriers: An International Hospital-Based Cohort Study.
Lambertini M, Blondeaux E, Agostinetto E, Hamy AS, Kim HJ, Di Meglio A, Bernstein Molho R, Hilbers F, Pogoda K, Carrasco E, Punie K, Bajpai J, Ignatiadis M, Moore HCF, Phillips KA, Toss A, Rousset-Jablonski C, Peccatori FA, Renaud T, Ferrari A, Paluch-Shimon S, Fruscio R, Cui W, Wong SM, Vernieri C, Ruddy KJ, Dieci MV, Matikas A, Rozenblit M, Villarreal-Garza C, De Marchis L, Del Mastro L, Puglisi F, Del Pilar Estevez-Diz M, Rodriguez-Wallberg KA, Mrinakova B, Meister S, Livraghi L, Clatot F, Yerushalmi R, De Angelis C, Sánchez-Bayona R, Meattini I, Cichowska-Cwalinska N, Berlière M, Salama M, De Giorgi U, Sonnenblick A, Chiodi C, Lee YJ, Maria C, Azim HA Jr, Boni L, Partridge AH; BRCA BCY Collaboration. Lambertini M, et al. Among authors: sonnenblick a. JAMA. 2024 Jan 2;331(1):49-59. doi: 10.1001/jama.2023.25463. JAMA. 2024. PMID: 38059899 Free PMC article.
Combining TIGIT Blockade with MDSC Inhibition Hinders Breast Cancer Bone Metastasis by Activating Antitumor Immunity.
Monteran L, Ershaid N, Scharff Y, Zoabi Y, Sanalla T, Ding Y, Pavlovsky A, Zait Y, Langer M, Caller T, Eldar-Boock A, Avivi C, Sonnenblick A, Satchi-Fainaro R, Barshack I, Shomron N, Zhang XH, Erez N. Monteran L, et al. Among authors: sonnenblick a. Cancer Discov. 2024 Jul 1;14(7):1252-1275. doi: 10.1158/2159-8290.CD-23-0762. Cancer Discov. 2024. PMID: 38427556
A clinical evaluation of an ex vivo organ culture system to predict patient response to cancer therapy.
Golan S, Bar V, Salpeter SJ, Neev G, Creiderman G, Kedar D, Aharon S, Turovsky L, Zundelevich A, Shahar H, Shapira H, Mallel G, Stossel E, Gavert N, Straussman R, Dotan Z, Berger R, Stossel C, Golan T, Halperin S, Leibovici D, Breuer S, Rottenberg Y, Applebaum L, Hubert A, Nechushtan H, Peretz T, Zick A, Chertin B, Koulikov D, Sonnenblick A, Rosenbaum E. Golan S, et al. Among authors: sonnenblick a. Front Med (Lausanne). 2023 Sep 28;10:1221484. doi: 10.3389/fmed.2023.1221484. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37840996 Free PMC article.
[GENOMIC PROFILING IN LUMINAL BREAST CANCER].
Raphael A, Sonnenblick A. Raphael A, et al. Among authors: sonnenblick a. Harefuah. 2022 Feb;161(2):104-109. Harefuah. 2022. PMID: 35195972 Review. Hebrew.
Patient-specific signaling signatures predict optimal therapeutic combinations for triple negative breast cancer.
Alkhatib H, Conage-Pough J, Roy Chowdhury S, Shian D, Zaid D, Rubinstein AM, Sonnenblick A, Peretz-Yablonsky T, Granit A, Carmon E, Kohale IN, Boughey JC, Goetz MP, Wang L, White FM, Kravchenko-Balasha N. Alkhatib H, et al. Among authors: sonnenblick a. Mol Cancer. 2024 Jan 16;23(1):17. doi: 10.1186/s12943-023-01921-9. Mol Cancer. 2024. PMID: 38229082 Free PMC article.
Metastatic breast cancer: The Odyssey of personalization.
Sonnenblick A, Pondé N, Piccart M. Sonnenblick A, et al. Mol Oncol. 2016 Oct;10(8):1147-59. doi: 10.1016/j.molonc.2016.07.002. Epub 2016 Jul 11. Mol Oncol. 2016. PMID: 27430154 Free PMC article. Review.
Heparanase: a potential marker of worse prognosis in estrogen receptor-positive breast cancer.
Zahavi T, Salmon-Divon M, Salgado R, Elkin M, Hermano E, Rubinstein AM, Francis PA, Di Leo A, Viale G, de Azambuja E, Ameye L, Sotiriou C, Salmon A, Kravchenko-Balasha N, Sonnenblick A. Zahavi T, et al. Among authors: sonnenblick a. NPJ Breast Cancer. 2021 May 28;7(1):67. doi: 10.1038/s41523-021-00277-x. NPJ Breast Cancer. 2021. PMID: 34050190 Free PMC article.
82 results